← Back to search
CHILDRENS HOSPITAL MEDICAL CENTER
CINCINNATI, OH, 45229
UnclaimedClaim this profile (free)
Prime contracting experience
20 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | 75D30123D18246USAspending | $894,604 | Sep 13, 2026 | Sep 28, 2023 – Sep 27, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | CISA RSV INFANTS STUDY (LEAD SITE) | 75D30123D18246USAspending | $709,088 | Jul 16, 2026 | Sep 27, 2024 – Sep 26, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | 75D30123D18246USAspending | $896,534 | Jun 9, 2026 | Sep 28, 2023 – Sep 27, 2026 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | IGF::OT::IGF CISA CHILDERN'S HOSPITAL MEDICAL CENTER | HHSD200201253661IUSAspending | $484,540 | Mar 21, 2026 | Sep 29, 2017 – Sep 28, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | VACCINE AND TREATMENT EVALUATION UNITS (VTEU) OVERALL ADMINISTRATION, CLINICAL OPERATIONS SUPPORT AND CONCEPT AND PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS TASK AREA A-D TASK ORDER FY.2019.A1B1C1D1.0103 | HHSN272201300016IUSAspending | $4,648,170 | Apr 21, 2025 | Jun 19, 2018 – Jul 31, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | 1300016I CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER; TO FY.2020.A1B1C1D1.0123--16 BASE AWARD; BIOD CAN 8470038 $314,043 | HHSN272201300016IUSAspending | $2,695,936 | Apr 21, 2025 | Jul 12, 2019 – Jul 31, 2025 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | PEDIATRIC COVID-19 VACCINATION IN YOUNG | HHSD200201253661IUSAspending | $518,366 | Aug 28, 2024 | Sep 29, 2022 – Dec 28, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS (VTEU)PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYSTASK AREA B-D PHASE 1 VACCINE TRIAL FOR EBOLA VIRUS TASK ORDER 14-0092.B1C1D1.0061 | HHSN272201300016IUSAspending | $2,911,460 | May 28, 2024 | Aug 18, 2017 – Dec 31, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | 1300016I CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER; TO 18-0011.B1C1.0116--16 BASE TASK ORDER FUNDING; BIOD CAN 8470038 $140,362 | HHSN272201300016IUSAspending | $604,888 | Apr 16, 2024 | Oct 15, 2018 – May 31, 2021 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | CISA COVID PEDIATRIC - CCHMC | HHSD200201253661IUSAspending | $697,191 | Nov 2, 2023 | Jan 1, 2021 – Dec 9, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | NEW TASK ORDER A78 AWARD | HHSN272201700017IUSAspending | $1,968,711 | Oct 16, 2023 | Nov 4, 2022 – Nov 3, 2024 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | CISA COVID ADULT STUDY CCHMC | HHSD200201253661IUSAspending | $889,592 | Sep 24, 2023 | Dec 3, 2020 – Sep 29, 2024 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | CISA COVID MATERNAL CONTRIBUTING CINCINNATI | HHSD200201253661IUSAspending | $697,827 | Sep 1, 2023 | Dec 3, 2020 – Sep 30, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | 1300016I CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER; TO 18-0010.B1C1.0120--16 BASE TASK ORDER FUNDING; BIOD 8470038 $74,436 | HHSN272201300016IUSAspending | $1,053,460 | Aug 17, 2023 | Apr 15, 2019 – Aug 31, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | TO ISSUE TASK ORDER A-05, "MOUSE AND GUINEA PIG MODELS FOR CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUSES." | HHSN272201700017IUSAspending | $3,496,526 | Jul 6, 2023 | Nov 1, 2017 – Jul 7, 2023 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | PEDIATRIC COVID-19 VACCINATION IN YOUNG CHILDREN RCT (CONTRIBUTING SITE) | HHSD200201253661IUSAspending | $277,830 | Nov 3, 2022 | Sep 29, 2022 – Sep 27, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS (VTEU) PROTOCOL DEVELOPMENT AND IMPLEMENTATION TASK AREA B-C PHASE II VACCINE TRIAL FOR INFLUENZA TASK ORDER | HHSN272201300016IUSAspending | $2,955,503 | Sep 13, 2022 | Jul 28, 2017 – Dec 31, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF AWARD OF VACCINE AND TREATMENT EVALUATION UNITS (VTEU) | HHSN272201300016IUSAspending | $2,617,180 | Sep 12, 2022 | Jul 10, 2017 – Jun 30, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF VACCINE AND TREATMENT EVALUATION UNITS | HHSN272201300016IUSAspending | $1,273,326 | Jun 14, 2022 | Jun 12, 2017 – Aug 31, 2022 |
| Prime | Department of Health and Human Services Food and Drug Administration | BAA 159 PREVENTABLE HARM FROM PEDIATRIC OUTPATIENT MEDICATION ERRORS MEASURE DEVELOPMENT | — | $435,308 | Dec 1, 2021 | Sep 29, 2020 – Dec 30, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
8 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | DR. HAGAN WILL BE RESPONSIBLE FOR PERFORMING AND SUPERVISING THE DATA ANALYSIS OF ADJUVANT DATASETS DESCRIBED IN THE PROPOSAL AND WRITING THE SCIENTIFIC PAPERS. HE WILL PROVIDE TRAINING, GUIDANCE, AND TECHNICAL ASSISTANCE TO THE POSTDOCTORAL FELLOW, WHO WILL BE ASSISTING IN THE DATA ANALYSIS. DR. HAGAN WILL ALSO WORK WITH THE OTHER PIS TO ENSURE COORDINATED ANALYSES AND DISCUSSION OF THE WORK DESCRIBED IN THE PROPOSAL. 63008243-240857 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: CA Parent award description: ADJUVANT COMPARISON AND CHARACTERIZATION View parent award on USAspending | — | $153,033 | May 5, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | DESIGN AND CONDUCT A HYBRID TYPE 3 STUDY TO IMPLEMENT DOXYCYCLINE POST- EXPOSURE PROPHYLAXIS (DOXY PEP) IN GAY, BISEXUAL, AND OTHER MEN WHO HAVE SEX WITH MEN (GBMSM), A POPULATION FOR WHICH THERE EXISTS RECOMMENDATIONS IN THE USE OF DOXY PEP ON THE BASIS OF DEMONSTRATED EFFICACY OF THE DOXY PEP IN STI PREVENTION. 000545627-SC003-WID Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541990 Parent award performance state: GA Parent award description: STIIRC SUPPORT SERVICES View parent award on USAspending | 75D30123D15974USAspending | $22,722 | Feb 10, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | DR. HAGAN WILL BE RESPONSIBLE FOR PERFORMING AND SUPERVISING THE DATA ANALYSIS OF ADJUVANT DATASETS DESCRIBED IN THE PROPOSAL AND WRITING THE SCIENTIFIC PAPERS. HE WILL PROVIDE TRAINING, GUIDANCE, AND TECHNICAL ASSISTANCE TO THE POSTDOCTORAL FELLOW, WHO WILL BE ASSISTING IN THE DATA ANALYSIS. DR. HAGAN WILL ALSO WORK WITH THE OTHER PIS TO ENSURE COORDINATED ANALYSES AND DISCUSSION OF THE WORK DESCRIBED IN THE PROPOSAL. 63008243-240857 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: CA Parent award description: ADJUVANT COMPARISON AND CHARACTERIZATION View parent award on USAspending | — | $148,670 | Apr 29, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | DEVELOPMENT, VALIDATION & USE OF BIOTINYLATION TO MEASURE POST-TRANSFUSION RED BLOOD CELL KINETICS IN THE
CONTEXT OF REGULATORY STUDIES FOR THE APPROVAL OF NOVEL OR MODIFIED BLOOD PRODUCTS IN THE USA 01554800002 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 611310 Parent award performance state: OH Parent award description: THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51 AS THE STANDARD FDA-APPROVED TECHNOLOGY FOR ASSESSING THE LIFESPAN OF RBCS IN CIRCULATION. View parent award on USAspending | — | $41,881 | Dec 13, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | DR. HAGAN WILL BE RESPONSIBLE FOR PERFORMING AND SUPERVISING THE DATA ANALYSIS OF ADJUVANT DATASETS DESCRIBED IN THE PROPOSAL AND WRITING THE SCIENTIFIC PAPERS. HE WILL PROVIDE TRAINING, GUIDANCE, AND TECHNICAL ASSISTANCE TO THE POSTDOCTORAL FELLOW, WHO WILL BE ASSISTING IN THE DATA ANALYSIS. DR. HAGAN WILL ALSO WORK WITH THE OTHER PIS TO ENSURE COORDINATED ANALYSES AND DISCUSSION OF THE WORK DESCRIBED IN THE PROPOSAL. 63008243-240857 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: CA Parent award description: ADJUVANT COMPARISON AND CHARACTERIZATION View parent award on USAspending | — | $144,431 | Mar 1, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | DR. DANZIGER-LSAKOV WILL SERVE AS THE CCHMC SITE-PL OVERSEEING IRS SUBMISSION AND IRS MAINTENANCE
FOR THE STUDY, AS WELL AS PATIENT SCREENING, ENROLLMENT, DATA ENTRY INTO THE CENTRAL REDCAP‎¢DATABASE,
AND SPECIMEN COLLECTION AND SHIPMENT TO LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE
(LBERI). THEY WILL WORK CLOSELY WITH THE CCHMC BONE MARROW TRANSPLANT TEAM'S STUDY CO-INVESTIGATOR,
DR.MIKE GRIMLEY,TO IDENTIFY AND ENROLL ELIGIBLE PATIENTS EACH OF THESE STUDY MEMBERS WILL CONTRIBUTE TO
PROTOCOL DEVELOPMENT,DATA CLEANING FOR THEIR SITE'S DATA, DISCUSSIONS ON DATA ANALYSES , AND MANUSCRIPT
PREPARATION.
STUDY COORDINATION
THE CCHMC STUDY COORDINATOR WILL BE RESPONSIBLE FOR THE DAY TO DAY ACTIVITIES OF THE PROJECT, INCLUDING
STUDY SETUP,PATIENT CONSENT/ASSENT AND ENROLLMENT, IRS COMPLIANCE, MAINTAINENANCE OF THE LOCAL MANUAL
OF PROCEDURES AND ENSURE THE COMPLETENESS/ACCURACY OF DATA ENTRY FOR CCHMC PATIENTS. THE CCHMC
STUDY COORDINATOR WILL WORK IN CONCERT WITH THE CHOP STUDY COORDINATOR TO MAINTAIN CONSTANT
COMMUNICATION REGARDING STUDY EXECUTION THROUGHOUT THE ENTIRETY OF THE STUDY PERIOD
PATIENTENROLLMENT,SAMPLE COLLECTION,AND DATA ENTRY
PRIORTOBEGINNINGANYSTUDY RELATEDACTIVITIES,APPROVALWILLBEOBTAINEDFROM CCHMC IRS.CCHMCSTUDY
STAFF WILL PROSPECTIVELY IDENTIFY, SCREEN AND ENROLL CHILDREN PLANNED TO UNDERGO ALLOGENEIC STEM CELL
TRANSPLANTATION. IT IS ESTIMATED THAT 130 TO 140 PATIENTS WILL BE ENROLLED DURING THE 40 MONTH ENROLLMENT
PERIOD AFTER PATIENT'SARECONSENTED/ASSENTEDTHEY WILLHAVEA BLOODSERUMANDSTOOLSPECIMENCOLLECTED
IN THE DAY -7 TO DAY 0 TIME PERIOD.THESE SPECIMENS WILL BE PROCESSED LOCALLY AND SHIPPED TO LBERI
ACCORDINGTOTHEPROTOCOLDETAILS.ADDITIONALLY ANY REMAININGCLINICALSPECIMENTHATWAS FOUNDTOBE POSITIVE
BYADENOVIRUSPCRDURINGTHESTUDY FOLLOW-UPPERIODWILLBE PROCESSED ANDSHIPPEDTO LBERIFORADDITONAL
TESTING STUDY STAFF WILL PROSPECTIVELY COLLECT DATA FROM THE PATIENT'S MEDICAL RECORD AND ENTER INTO THE
STUDY'SREDCAP‎¢DATABASE. PATIENTSWILLBEFOLLOWEDFOR UPTO 180DAYSFROMTRANSPLANTATION
DATA QUALITY CHECK
DATA WILL DOWNLOADED PERIODICALLY FROM THE REDCAP‎¢DATABASE BY LBERISTUDY STAFF AND GO THROUGH A
NUMBER OF DATA QUALITY CHECKS. ANY CONCERNS FOR MISSING OR INACCURATE DATA WILL BE QUERIED BACK TO THE
CCH STUDY STAFF FOR CORRECTING.
CONFERENCE CALLS AND STUDY MEETINGS
THESITE PLANDSTUDY COORDINATORWILLBEEXPECTEDTO PARTICIPATEINMONTHLYCONFERENCECALLS. ADDITIONALLY,
THE SITE PLWILL HEEXNECTED TO NARTICINATEIN A ST11DV KICK-OFF MEETINQ ANDYEARH1IN-NERSON SH1DY MEETJNAS FP00020404_SUB02_06 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541712 Parent award performance state: PA Parent award description: IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS View parent award on USAspending | — | $95,077 | Jul 28, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | CLINICAL PROTOCOL IMPLEMENTATION
� COMPLETE RECRUITING AND RETAINING 35% OF SITE�S STUDY SUBJECTS IN ACCORDANCE WITH THE MOST CURRENT APPROVED PROTOCOL.
� PROVIDE FOR THE PROPER STORAGE AND DISTRIBUTION OF THE STUDY PRODUCT.
� COMPLETE DATA COLLECTION AND DATA QUALITY MANAGEMENT PROCEDURES IN ACCORDANCE WITH THE MOST CURRENT APPROVED PROTOCOL.
� COMPLETE SPECIMEN COLLECTION ON ENROLLED SUBJECTS AND LABORATORY ANALYSIS ON SAMPLES COLLECTED IN ACCORDANCE WITH THE MOST CURRENT APPROVED PROTOCOL.
� SUPPORT SAFETY COMMITTEE AND SDCC IN THE DEVELOPMENT OF REQUIRED DOCUMENTATION FOR SAFETY OVERSIGHT.
� IDENTIFY AND MINIMIZE POTENTIAL PROBLEMS AND DIFFICULTIES ASSOCIATE WITH CONDUCTING THIS TRIAL, INCLUDING THOSE RELATED TO RECRUITMENT AND RETENTION, AND IDENTIFY AND IMPLEMENT RISK MITIGATION STRATEGIES AND REPORT ANY PROBLEMS AND PROPOSED RESOLUTIONS TO THE COR.
� COMPLETE PROTOCOL DEFINED ASSESSMENT AND SUBJECT FOLLOW-UP ON ENROLLED SUBJECTS IN ACCORDANCE WITH THE MOST CURRENT APPROVED PROTOCOL. SP0033779 60044358 CCHMC-01 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541712 Parent award performance state: IL Parent award description: IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS View parent award on USAspending | — | $179,125 | Nov 22, 2021 | — – — |
| Subcontractor | Department of Defense | THE BIOTECHNOLOGY HIGH PERFORMANCE COMPUTING SOFTWARE APPLICATIONS INSTITUTE (BHSAI) IS
PERFORMING STUDIES UNDER PRIME AWARD W81XWH-20-C-0031 TO SPECIFICALLY STUDY THE
PHYSIOLOGICAL MECHANISMS OF ACUTE PAIN GENERATION AT THE LEVEL OF PRIMARY AFFERENT NEURONS AND
SENSITIZATION OF THOSE NEURONS BY INFLAMMATORY MEDIATORS LEADING TO THE TRANSITION OF ACUTE PAIN
INTO CHRONIC PAIN. TO ACCOMPLISH THIS OBJECTIVE, BHSAI RESEARCH SCIENTISTS WILL FIRST DEVELOP A
COMPUTATIONAL MODEL OF THE PERIPHERAL TERMINAL OF AFFERENT SENSORY NEURONS. THEY WILL USE THIS
MODEL TO PREDICT KEY BIOCHEMICAL COMPONENTS (RECEPTORS AND ION CHANNELS) THAT CONTRIBUTE TO THE
GENERATION OF THE ELECTRICAL ACUTE PAIN SIGNAL (I.E., AN ACTION POTENTIAL) FOLLOWING APPLICATION OF A
PAINFUL MECHANICAL STIMULUS. NEXT, THEY WILL USE THE MODEL TO IDENTIFY THE NEUROBIOLOGICAL
ALTERATIONS (CHANGES IN THE EXPRESSION OF RECEPTORS AND ION CHANNELS, AS WELL AS LEVELS OF
INFLAMMATORY MEDIATORS AND SECOND MESSENGER MOLECULES) THAT SENSITIZE THE NEURON, WHICH
ULTIMATELY CONTRIBUTES TO THE TRANSITION OF NORMAL PHYSIOLOGICAL ACUTE PAIN INTO CHRONIC PAIN.
FINALLY, THEY WILL UTILIZE THE TECHNICAL EXPERTISE OF DR. JANKOWSKI AT THE CINCINNATI CHILDREN€„¢S
HOSPITAL MEDICAL CENTER AND THE UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE TO EXPERIMENTALLY
VERIFY THE COMPUTATIONAL-MODEL PREDICTIONS. SPECIFICALLY, DR. JANKOWSKI WILL PERFORM EX VIVO
RECORDINGS OF ACTION POTENTIALS IN THE DORSAL ROOT GANGLIA (DRGS) OF PRIMARY AFFERENT SENSORY
NEURONS INNERVATING THE HINDPAW MUSCLE IN ADULT MALE MICE UNDER DIFFERENT EXPERIMENTAL
CONDITIONS. THESE RECORDINGS WILL HELP VALIDATE THE KEY MODEL-IDENTIFIED BIOCHEMICAL COMPONENTS
INVOLVED IN THE GENERATION OF ACTION POTENTIALS AND THE ALTERATION OF NORMAL NEURONAL SIGNALING
THAT CAUSE NEURONAL SENSITIZATION. IN ADDITION, THESE DATA WILL INFORM FUTURE LARGE-ANIMAL STUDIES
INVESTIGATING EFFECTIVE PAIN MANAGEMENT STRATEGIES.
DR. JANKOWSKI HAS BEEN WORKING IN THE FIELD OF NEUROSCIENCE FOR THE PAST 18 YEARS. IN 2011, HE
DEVELOPED AN INDEPENDENT RESEARCH PROGRAM AT THE CINCINNATI CHILDREN€„¢S HOSPITAL MEDICAL CENTER
TO STUDY THE PERIPHERAL MECHANISMS OF PAIN DEVELOPMENT USING AN EX VIVO SOMATOSENSORY
RECORDING PREPARATION. HIS FOCUS AND EXPERTISE IS IN MUSCLE AFFERENT FUNCTION AND THE DEVELOPMENT
OF VARIOUS MYALGIAS IN ADULTS AND NEONATES. HE WILL PERFORM EXPERIMENTS TO RECORD THE ACTION
POTENTIAL CHANGES IN THE DRGS OF PRIMARY AFFERENT MOUSE NEURONS AFTER THE APPLICATION OF
MECHANICAL STIMULI IN WILD-TYPE AND GENETICALLY MODIFIED MICE OR IN WILD-TYPE MICE WITH DIFFERENT
MODEL-PREDICTED PHARMACOLOGICAL MANIPULATIONS. COLLECTIVELY, THESE EFFORTS WILL HELP THE
COMMUNITY TO UNDERSTAND HOW ACTION POTENTIALS ARE GENERATED IN PRIMARY AFFERENT NEURONS IN THE MUSCLE AND THE
NEUROBIOLOGICAL CHANGES THAT SENSITIZE THESE NEURONS. 5793 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541715 Parent award performance state: MD Parent award description: MILITARY READINESS RESEARCH SUPPORT SERVICES View parent award on USAspending | — | $35,441 | Nov 15, 2021 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.